- Home
- SCPH vs BMN Comparison
SCPH vs BMN Comparison
Compare SCPH & BMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- BMN
- Stock Information
- Founded
- SCPH 2013
- BMN 2020
- Country
- SCPH United States
- BMN United States
- Employees
- SCPH N/A
- BMN 19800
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- BMN Trusts Except Educational Religious and Charitable
- Sector
- SCPH Health Care
- BMN Finance
- Exchange
- SCPH Nasdaq
- BMN Nasdaq
- Market Cap
- SCPH 173.6M
- BMN 153.0M
- IPO Year
- SCPH 2017
- BMN N/A
- Fundamental
- Price
- SCPH $5.17
- BMN $24.15
- Analyst Decision
- SCPH Strong Buy
- BMN
- Analyst Count
- SCPH 3
- BMN 0
- Target Price
- SCPH $14.00
- BMN N/A
- AVG Volume (30 Days)
- SCPH 307.4K
- BMN 29.9K
- Earning Date
- SCPH 08-13-2025
- BMN 01-01-0001
- Dividend Yield
- SCPH N/A
- BMN 4.66%
- EPS Growth
- SCPH N/A
- BMN N/A
- EPS
- SCPH N/A
- BMN N/A
- Revenue
- SCPH $41,982,000.00
- BMN N/A
- Revenue This Year
- SCPH $108.95
- BMN N/A
- Revenue Next Year
- SCPH $73.83
- BMN N/A
- P/E Ratio
- SCPH N/A
- BMN N/A
- Revenue Growth
- SCPH 138.10
- BMN N/A
- 52 Week Low
- SCPH $1.94
- BMN $21.51
- 52 Week High
- SCPH $6.28
- BMN $25.59
- Technical
- Relative Strength Index (RSI)
- SCPH 59.99
- BMN 37.71
- Support Level
- SCPH $5.37
- BMN $23.96
- Resistance Level
- SCPH $5.70
- BMN $25.09
- Average True Range (ATR)
- SCPH 0.32
- BMN 0.37
- MACD
- SCPH -0.02
- BMN -0.08
- Stochastic Oscillator
- SCPH 42.19
- BMN 10.11
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About BMN BlackRock 2037 Municipal Target Term Trust of Beneficial Interest
BlackRock 2037 Mun Tgt is a non-diversified, closed-end management investment company. The Trust's investment objective is to provide current income that is exempt from regular federal income tax. The Trust invests in investment grade quality securities or securities that are unrated but judged to be of comparable quality by the investment adviser.